Liver Injury and Elevated FIB-4 Define a High-Risk Group in Patients with COVID-19
Article
[키워드] Admission
Analysis
aspartate
AST
AST/ALT
AUROC
Biochemistry
characteristic
Computed tomography
conducted
consecutive patient
COVID-19
disease
elevated
Elevation
evaluate
FIB-4
fibrosis
Fibrosis-4
group
heterogeneous
hospitalized COVID-19 patients
liver
Liver disease
liver steatosis
liver test
Liver tests
Mortality
Non-invasive
outcome
Patient
patients with moderate
Prognosis
retrospective cohort study
severe COVID-19
significantly higher
steatosis
survival
susceptible
threshold
with COVID-19
[DOI] 10.3390/jcm11010153 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/jcm11010153 PMC 바로가기 [Article Type] Article